Abbas Ebrahimi‐Kalan

2.9k total citations · 1 hit paper
69 papers, 2.1k citations indexed

About

Abbas Ebrahimi‐Kalan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Abbas Ebrahimi‐Kalan has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Abbas Ebrahimi‐Kalan's work include MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (7 papers) and Spinal Cord Injury Research (7 papers). Abbas Ebrahimi‐Kalan is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (7 papers) and Spinal Cord Injury Research (7 papers). Abbas Ebrahimi‐Kalan collaborates with scholars based in Iran, United States and Türkiye. Abbas Ebrahimi‐Kalan's co-authors include Rana Jahanban‐Esfahlan, Khaled Seidi, Leila Roshangar, Tahereh Javaheri, Payman Zare, Saeed Kolahian, Roghayyeh Baghban, Mehdi Jaymand, Ahmad Mehdipour and Mohammad Reza Alipour and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and International Journal of Pharmaceutics.

In The Last Decade

Abbas Ebrahimi‐Kalan

60 papers receiving 2.0k citations

Hit Papers

Tumor microenvironment complexity and therapeutic implica... 2020 2026 2022 2024 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor microenvironment complexity and therapeutic implications at a glance
    2020 1.2k citations Abbas Ebrahimi‐Kalan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abbas Ebrahimi‐Kalan Iran 17 762 565 424 395 373 69 2.1k
Yunyun Xu China 23 936 1.2× 510 0.9× 470 1.1× 332 0.8× 435 1.2× 78 2.7k
Ran Tian China 24 1.0k 1.3× 320 0.6× 460 1.1× 270 0.7× 223 0.6× 40 1.9k
Amirali B. Bukhari India 12 730 1.0× 347 0.6× 329 0.8× 186 0.5× 182 0.5× 15 1.7k
Sebastian Strieth Germany 26 788 1.0× 385 0.7× 461 1.1× 217 0.5× 198 0.5× 130 2.3k
Qian Xiao China 27 1.3k 1.6× 952 1.7× 261 0.6× 609 1.5× 509 1.4× 111 2.7k
Han Zhou China 24 678 0.9× 254 0.4× 411 1.0× 263 0.7× 275 0.7× 64 1.8k
Young Suk Yu South Korea 32 1.4k 1.8× 344 0.6× 263 0.6× 260 0.7× 230 0.6× 124 3.1k
Yunxiang Zhou China 20 784 1.0× 276 0.5× 468 1.1× 222 0.6× 245 0.7× 43 2.1k
Владимир П. Баклаушев Russia 26 725 1.0× 393 0.7× 386 0.9× 160 0.4× 176 0.5× 157 2.2k

Countries citing papers authored by Abbas Ebrahimi‐Kalan

Since Specialization
Citations

This map shows the geographic impact of Abbas Ebrahimi‐Kalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Ebrahimi‐Kalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Ebrahimi‐Kalan more than expected).

Fields of papers citing papers by Abbas Ebrahimi‐Kalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Ebrahimi‐Kalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Ebrahimi‐Kalan. The network helps show where Abbas Ebrahimi‐Kalan may publish in the future.

Co-authorship network of co-authors of Abbas Ebrahimi‐Kalan

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Ebrahimi‐Kalan. A scholar is included among the top collaborators of Abbas Ebrahimi‐Kalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Ebrahimi‐Kalan. Abbas Ebrahimi‐Kalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebrahimi‐Kalan, Abbas, et al.. (2025). Cerebrolysin-loaded platelet-rich plasma exosomes: Restoring immune homeostasis via TNF-α/IL-10 modulation and apoptosis targeting for spinal cord injury repair. Journal of Spinal Cord Medicine. 49(2). 375–387. 1 indexed citations
2.
Ebrahimi‐Kalan, Abbas, et al.. (2025). The role of Autophagy in long-term effects of Spinal Cord Injury: Does Exosome change the Autophagy process and vice versa?. Advanced Pharmaceutical Bulletin. 15(3). 506–520.
3.
Mousazadeh, Hanieh, et al.. (2025). An update on the effect of metals on stemness properties of mesenchymal stem cells. Journal of Materials Science Materials in Medicine. 36(1). 44–44.
4.
Karimi, Abbas, et al.. (2024). Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review. Advanced Pharmaceutical Bulletin. 14(3). 543–557. 1 indexed citations
5.
Karimi, Abbas, et al.. (2024). Assessment of Platelet-Rich Plasma (PRP) Effects on the Proliferation and Apoptosis of Cyclophosphamide-Induced Damage in Human Granulosa Cells. Pharmaceutical Sciences. 30(2). 204–214. 3 indexed citations
6.
Kucian, Karin, et al.. (2024). Challenges Faced by People with Learning Difficulties Two Years after the COVID-19 Outbreak. Lernen und Lernstörungen. 13(4). 205–214.
7.
8.
Milani, Morteza, et al.. (2024). Targeting key players in lipid biosynthesis for NAFLD and NASH treatment. Cellular and Molecular Biology. 70(10). 117–133.
9.
Rahmani, Bita, et al.. (2023). Nutritional knowledge, attitude, and practice of professional athletes in an Iranian population (a cross-sectional study). BMC Sports Science Medicine and Rehabilitation. 15(1). 164–164. 5 indexed citations
10.
Geranmayeh, Mohammad Hossein, et al.. (2023). A new insight into the role of pericytes in ischemic stroke. Acta Neurologica Belgica. 124(3). 767–774. 5 indexed citations
11.
Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2023). STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance. International Immunopharmacology. 119. 110160–110160. 7 indexed citations
12.
Zarebkohan, Amir, et al.. (2023). Neurotrophic factors loaded TGN-modified chitosan nanoparticles ameliorate symptoms of MS through GATA3/FOXP3 and targeting Th1/2 cells pathways. Journal of Drug Delivery Science and Technology. 85. 104570–104570. 2 indexed citations
13.
Nakhjavani, Sattar Akbari, Mohammad Reza Alivand, Nosratollah Zarghami, et al.. (2022). Sensitive and Convenient Detection of miRNA-145 Using a Gold Nanoparticle-HCR Coupled System: Computational and Validations. IEEE Transactions on NanoBioscience. 22(1). 155–162. 11 indexed citations
14.
Milani, Morteza, et al.. (2021). An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?. Public health reviews. 42. 1604061–1604061. 6 indexed citations
15.
Fakhim, Hamed, et al.. (2020). Strategies for Isothermal Amplification of Nucleic Acids: are they Ready to be Applied in Point of Care Diagnosis of Mycosis?. Biointerface Research in Applied Chemistry. 11(3). 10559–10571. 2 indexed citations
16.
Ebrahimi‐Kalan, Abbas, et al.. (2020). The Role of Mammalian Target of Rapamycine Signaling Pathway in Central Nervous System Cancers: A Review. SHILAP Revista de lepidopterología. 24(5). 472–485. 1 indexed citations
17.
Ebrahimi‐Kalan, Abbas, et al.. (2018). Telomerase activity and telomere on stem progeny senescence. Biomedicine & Pharmacotherapy. 102. 9–17. 26 indexed citations
18.
Ebrahimi‐Kalan, Abbas, et al.. (2018). Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism. Biomedicine & Pharmacotherapy. 109. 1306–1312. 18 indexed citations
19.
Ebrahimi‐Kalan, Abbas, et al.. (2017). Regulation and roles of CD26/DPPIV in hematopoiesis and diseases. Biomedicine & Pharmacotherapy. 91. 88–94. 26 indexed citations
20.
Ebrahimi‐Kalan, Abbas, et al.. (2014). MS14, a Marine Herbal Medicine, an Immunosuppressive Drug in Experimental Autoimmune Encephalomyelitis. Iranian Red Crescent Medical Journal. 16(7). e16956–e16956. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunyun Xu Breakdown of academic impact, for papers by Ran Tian Breakdown of academic impact, for papers by Amirali B. Bukhari Breakdown of academic impact, for papers by Sebastian Strieth Breakdown of academic impact, for papers by Qian Xiao Breakdown of academic impact, for papers by Han Zhou Breakdown of academic impact, for papers by Young Suk Yu Breakdown of academic impact, for papers by Yunxiang Zhou Breakdown of academic impact, for papers by Владимир П. Баклаушев
Rankless by CCL
2026